Ads
related to: novartis- About Us
We Help You Find the Right Software
With a Free, Expert Consultation
- Research & Advice
The Latest Software Research
For Buyers Like You
- About Us
Search results
Exploring Novartis And Two More High-Yield Dividend Stocks In Switzerland
Simply Wall St. via Yahoo Finance· 5 hours agoThe Switzerland market recently experienced a moderate decline, influenced by investor concerns that...
Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Novartis AG...
Capital Research Global Investors Increases Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 7 days agoCapital Research Global Investors raised its position in shares of Novartis AG (NYSE:NVS – Free Report) by 0.0% in the 4th quarter, according to its most recent 13F filing ...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 1 day agoThe move follows similar billion-dollar-plus transactions made in recent months by Bristol Myers Squibb (BMS) and Eli Lilly, along with earlier takeovers...
Study Elucidates Skin Signs of VEXAS Syndrome
Medscape· 4 hours agoSkin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....
Erasca (NASDAQ:ERAS) vs. Ascendis Pharma A/S (NASDAQ:ASND) Head-To-Head Contrast
ETF DAILY NEWS· 6 hours agoErasca (NASDAQ:ERAS – Get Free Report) and Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses ...
NHS and ABPI announce new guidelines ahead of UK elections
Pharmaceutical Technology via Yahoo Finance· 15 hours agoSpeaking on a panel discussing the guidelines, Pauline Hakutangwi, value and access marketing...
UC Irvine researchers project cardiac benefits from weight-loss medication tirzepatide
UC Irvine Today· 4 days agoNew study finds that popular weight-loss medication may reduce the number of U.S. adults with obesity by 55 million and prevent up to 2 million heart attacks and strokes over a 10-year period ...
Why Alcon (ALC) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoFrom Mar 20, 2002 until its 2011-merger into Novartis, Alcon was publicly listed and traded on the...
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 4 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...